Epps, C., Bax, R., Croker, A., Green, D., Gropman, A., Klein, A. V., . . . Davis, J. M. (2022). Global Regulatory and Public Health Initiatives to Advance Pediatric Drug Development for Rare Diseases. Therapeutic Innovation & Regulatory Science, 56(6), 964-975. https://doi.org/10.1007/s43441-022-00409-w
Chicago Style (17th ed.) CitationEpps, Carla, et al. "Global Regulatory and Public Health Initiatives to Advance Pediatric Drug Development for Rare Diseases." Therapeutic Innovation & Regulatory Science 56, no. 6 (2022): 964-975. https://doi.org/10.1007/s43441-022-00409-w.
MLA (9th ed.) CitationEpps, Carla, et al. "Global Regulatory and Public Health Initiatives to Advance Pediatric Drug Development for Rare Diseases." Therapeutic Innovation & Regulatory Science, vol. 56, no. 6, 2022, pp. 964-975, https://doi.org/10.1007/s43441-022-00409-w.